ctrl K

Watchlist Price Alert

Anebulo Pharmaceuticals I... (ANEB)

NASDAQ: ANEB · Real-Time Price · USD

1.32

-0.10 (-7.04%)

At close: Jun 27, 2025, 3:03 PM

Anebulo Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	3.09M	11.25M	14.55M	19.99M	3.02M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	565.12K	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	3.5K
Inventory	n/a	n/a	n/a	n/a	-3.5
Other Current Assets	n/a	n/a	n/a	n/a	n/a
Total Current Assets	3.51M	11.25M	14.55M	19.99M	3.03M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	565.12K	n/a	1.03M	1.67M	n/a
Total Assets	4.07M	11.67M	15.58M	21.65M	3.03M
Account Payables	156.43K	534.54K	380.83K	110.05K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	201.29K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	260.58K	534.54K	512.53K	241.63K	223.87K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	0.00	534.26K	380.83K	131.59K	2.98M
Total Liabilities	260.58K	1.07M	512.53K	241.63K	3.2M
Total Debt	n/a	n/a	n/a	n/a	201.29K
Common Stock	25.93K	25.63K	23.34K	23.34K	12K
Retained Earnings	-65.4M	-57.2M	-45.47M	-38.64M	-183.14K
Comprehensive Income	n/a	0.00	n/a	-21.65M	-2.99M
Shareholders Equity	3.81M	10.6M	15.07M	21.41M	-171.14K
Total Investments	n/a	n/a	n/a	n/a	n/a